Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease

This publication has 13 references indexed in Scilit:

• Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases
  The American Journal of Medicine, 2001
• Serious adverse events experienced by patients with chronic heart failure taking spironolactone
  Heart, 2001
• Elderly heart failure patients with drug-induced serious hyperkalemia
  Aging Clinical and Experimental Research, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Renal function in the elderly: Impact of hypertension and cardiac function
  Kidney International, 1997
• Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
  Journal of Cardiac Failure, 1996
• Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor
  The American Journal of Cardiology, 1993
• Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors
  The Journal of Clinical Pharmacology, 1993
• Age-Related Changes in the Renin-Aldosterone System
  Drugs & Aging, 1993
• Prediction of Creatinine Clearance from Serum Creatinine
  Nephron, 1976